Blood Collection Devices Market Set for Steady Growth to USD 16.32 Billion by 2035, Led by North America's 40.7% Market Share | DataM Intelligence

The Global Blood Collection Devices Market is valued at approximately USD 8.51 billion in 2025 and is projected to reach about USD 16.32 billion by 2035, growing at a CAGR of around 6.5% during the forecast period from 2025 to 2035.

This robust growth is driven by the rising demand for diagnostic testing, escalating prevalence of chronic diseases, increasing blood donations, advancements in technologies like safety-engineered needles and vacuum-based systems, and expanding healthcare infrastructure worldwide.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/blood-collection-devices-market?ram

Asia Pacific / Japan: Key Industry Developments
✅ November 2025: Japan blood collection devices market valued at USD 458.8 million, driven by aging population and chronic disease prevalence boosting demand for tubes, needles, and safety systems in hospitals.​

✅ August 2025: Industry trends highlight advancements in safety blood collection sets with retractable needles and smart tech integration to reduce needlestick injuries and enhance tracking.​

✅ March 2025: Asia-Pacific blood collection market projected robust growth from USD 985.91 million in 2024, fueled by expanding healthcare infrastructure.​

Key Merges and Acquisitions(2025):
✅ Becton, Dickinson and Company (BD) acquires specimatch GmbH (Indirect Impact): In early 2025, BD announced the acquisition of specimatch GmbH, a company focused on pre-analytical sample matching solutions. This deal enhances patient safety and diagnostic accuracy, demonstrating a broader industry trend toward improving the end-to-end blood collection workflow, from sample collection to analysis.

✅ Thermo Fisher Scientific opens new bio-production facility in India (Indirect Impact): In mid-2025, Thermo Fisher opened a new facility to support the production of biological therapies. This investment in manufacturing infrastructure reflects the significant demand for high-quality components for the life sciences and healthcare sectors, including advanced blood collection and processing products.

✅ General Mills acquires BellRing Brands, Inc. (Indirect Impact): While in the food sector, General Mills' $4.5 billion acquisition of health and wellness brands in July 2025 highlights a market-wide focus on health-conscious products. In the medical device industry, this translates to an increasing demand for innovative, patient-centric blood collection devices that improve comfort and user experience.

Market Segmentation Analysis:
-By Product: Tubes Lead with Dominant Share
Blood collection tubes hold 33.8% market share in 2024, driven by rising chronic diseases and routine diagnostics needing stable samples.​
Needles & syringes follow as a key segment for direct venipuncture, while blood bags support transfusions; blood collection systems/monitors and lancets enable monitoring and capillary draws.​
Tubes dominate due to innovations in additives enhancing lab efficiency.​

-By Method: Manual Prevails for Cost-Effectiveness
Manual blood collection commands 67.1% share in 2024, favored for low costs, broad use in clinics, and patient comfort via improved needles.​
Automated collection grows via efficiency gains but trails due to higher setup needs.​

-By Application: Diagnostics Drives Demand
Diagnostics leads with 65.6% share in 2024, fueled by blood tests for cancer, diabetes, and cardiovascular monitoring.​
Therapeutics supports treatments like transfusions but holds smaller volume.​

-By End-User: Hospitals Command Volume
Hospitals capture 34.2% share in 2024 from high test volumes, surgeries, and transfusions.​
Diagnostic & pathology labs, blood banks, and ambulatory centers follow for specialized testing;

Purchase this report before year-end and unlock an exclusive 30% discount: https://www.datamintelligence.com/buy-now-page?report=blood-collection-devices-market?ram (Purchase 2 or more Reports and get 50% Discount)

Growth Drivers:
-Rising prevalence of chronic diseases like diabetes, cancer, cardiovascular disorders, and infectious diseases, necessitating frequent blood testing for diagnosis, monitoring, and management.​

-Increasing demand for blood transfusions, donations, and blood products in surgeries, trauma care, and disease management.​

-Advancements in blood collection technologies, including automated systems, safety-engineered needles, minimally invasive techniques, and point-of-care devices that enhance efficiency, patient safety, and sample integrity.​

-Expansion of healthcare infrastructure, diagnostic facilities, and point-of-care testing, particularly in emerging economies like those in Asia Pacific.​

-Growing emphasis on preventive healthcare, early disease detection, regular health screenings, and awareness of safe blood collection practices.​

Regional Insights:
-North America leads the Blood Collection Devices Market with the largest share at 40.7% in 2024, driven by advanced healthcare infrastructure, high diagnostic testing volumes, substantial R&D investments, and the presence of major manufacturers like Becton Dickinson.​

-Europe follows as the second-largest region, benefiting from well-developed healthcare systems, stringent regulatory standards for blood safety, and widespread adoption of innovative collection technologies across hospitals and labs.​

-Asia Pacific ranks third in market share and exhibits the fastest growth potential with a projected CAGR of 8.6% from 2025 to 2032, fueled by rapid urbanization, rising healthcare expenditures, increasing chronic disease prevalence, and expanding diagnostic access in countries like China, India, and Japan.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/blood-collection-devices-market?ram

Key Players:
Cardinal Health | Becton Dickinson and Company | Medline Industries, LP | Greiner Bio-One International GmbH | Henry Schein, Inc. | TERUMO BCT, INC. | Fresenius Kabi AG | Grifols, S.A. | Nipro Medical Corporation | Smith's Medical

Key Highlights (Top 5 Key Players) for Blood Collection Devices Market:
-Becton, Dickinson and Company (BD) leads the market with its extensive range of blood collection tubes, needles, and safety-engineered devices widely adopted in hospitals and diagnostic labs.​

-Fresenius Kabi AG holds a prominent position through advanced whole-blood and apheresis collection systems that improve donor safety and efficiency.​

-Terumo BCT, Inc. drives growth with cutting-edge blood component technologies and integrated collection systems for therapeutic applications.​

-Greiner Bio-One International GmbH contributes via high-quality VACUETTE blood collection products ensuring sample integrity for automated analyzers.​

-Cardinal Health strengthens its role with a broad portfolio of medical and laboratory supplies backed by extensive distribution networks.​

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?ram

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.